Financhill
Buy
70

DCTH Quote, Financials, Valuation and Earnings

Last price:
$16.18
Seasonality move :
-1.39%
Day range:
$16.12 - $16.81
52-week range:
$6.33 - $18.23
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
10.08x
P/B ratio:
7.12x
Volume:
793.2K
Avg. volume:
483.8K
1-year change:
110.93%
Market cap:
$571.5M
Revenue:
$37.2M
EPS (TTM):
-$0.50

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
DCTH
Delcath Systems
$16.8M $0.03 179.13% -93.78% $24.08
CTSO
CytoSorbents
$9M -$0.07 10.68% -41.38% $5.00
EXAS
Exact Sciences
$688.6M -$0.10 10.52% -84.17% $68.83
ILMN
Illumina
$1B $0.94 -5.72% 430.2% $106.53
NTRA
Natera
$446.7M -$0.66 15.16% -106.89% $191.91
STRR
Star Equity Holdings
$16.4M -$0.25 24.23% -43.28% $8.50
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
DCTH
Delcath Systems
$16.41 $24.08 $571.5M -- $0.00 0% 10.08x
CTSO
CytoSorbents
$0.82 $5.00 $51.4M -- $0.00 0% 1.30x
EXAS
Exact Sciences
$56.56 $68.83 $10.7B -- $0.00 0% 3.71x
ILMN
Illumina
$82.49 $106.53 $13.1B -- $0.00 0% 3.03x
NTRA
Natera
$157.16 $191.91 $21.5B -- $0.00 0% 11.00x
STRR
Star Equity Holdings
$2.05 $8.50 $6.6M 0.75x $0.00 0% 0.11x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
DCTH
Delcath Systems
-- 2.997 -- 13.86x
CTSO
CytoSorbents
49.38% 1.160 22.69% 1.98x
EXAS
Exact Sciences
49.21% 0.148 28.45% 2.12x
ILMN
Illumina
45.66% 0.950 15.77% 1.34x
NTRA
Natera
6.09% 3.386 0.42% 3.58x
STRR
Star Equity Holdings
18.39% -0.314 40.47% 0.69x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
DCTH
Delcath Systems
$16.9M $642K -37.34% -40.28% 3.25% $2.1M
CTSO
CytoSorbents
$6.2M -$3.9M -58.93% -106.57% -10.01% -$3.5M
EXAS
Exact Sciences
$500.5M -$89.8M -19.08% -35.57% -13.04% -$365K
ILMN
Illumina
$683M $164M -20.34% -34.38% 19.89% $201M
NTRA
Natera
$316.8M -$79.2M -15.3% -19.19% -13.1% $22.6M
STRR
Star Equity Holdings
$3.1M -$2.8M -13.58% -15.99% -22.03% $200K

Delcath Systems vs. Competitors

  • Which has Higher Returns DCTH or CTSO?

    CytoSorbents has a net margin of 5.4% compared to Delcath Systems's net margin of -16.94%. Delcath Systems's return on equity of -40.28% beat CytoSorbents's return on equity of -106.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    DCTH
    Delcath Systems
    85.62% $0.03 $80.2M
    CTSO
    CytoSorbents
    71.13% -$0.02 $28.7M
  • What do Analysts Say About DCTH or CTSO?

    Delcath Systems has a consensus price target of $24.08, signalling upside risk potential of 46.73%. On the other hand CytoSorbents has an analysts' consensus of $5.00 which suggests that it could grow by 509.24%. Given that CytoSorbents has higher upside potential than Delcath Systems, analysts believe CytoSorbents is more attractive than Delcath Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    DCTH
    Delcath Systems
    4 0 0
    CTSO
    CytoSorbents
    1 1 0
  • Is DCTH or CTSO More Risky?

    Delcath Systems has a beta of 0.722, which suggesting that the stock is 27.805% less volatile than S&P 500. In comparison CytoSorbents has a beta of 1.171, suggesting its more volatile than the S&P 500 by 17.12%.

  • Which is a Better Dividend Stock DCTH or CTSO?

    Delcath Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CytoSorbents offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Delcath Systems pays -- of its earnings as a dividend. CytoSorbents pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DCTH or CTSO?

    Delcath Systems quarterly revenues are $19.8M, which are larger than CytoSorbents quarterly revenues of $8.7M. Delcath Systems's net income of $1.1M is higher than CytoSorbents's net income of -$1.5M. Notably, Delcath Systems's price-to-earnings ratio is -- while CytoSorbents's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Delcath Systems is 10.08x versus 1.30x for CytoSorbents. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DCTH
    Delcath Systems
    10.08x -- $19.8M $1.1M
    CTSO
    CytoSorbents
    1.30x -- $8.7M -$1.5M
  • Which has Higher Returns DCTH or EXAS?

    Exact Sciences has a net margin of 5.4% compared to Delcath Systems's net margin of -14.32%. Delcath Systems's return on equity of -40.28% beat Exact Sciences's return on equity of -35.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    DCTH
    Delcath Systems
    85.62% $0.03 $80.2M
    EXAS
    Exact Sciences
    70.82% -$0.54 $4.7B
  • What do Analysts Say About DCTH or EXAS?

    Delcath Systems has a consensus price target of $24.08, signalling upside risk potential of 46.73%. On the other hand Exact Sciences has an analysts' consensus of $68.83 which suggests that it could grow by 21.7%. Given that Delcath Systems has higher upside potential than Exact Sciences, analysts believe Delcath Systems is more attractive than Exact Sciences.

    Company Buy Ratings Hold Ratings Sell Ratings
    DCTH
    Delcath Systems
    4 0 0
    EXAS
    Exact Sciences
    18 4 0
  • Is DCTH or EXAS More Risky?

    Delcath Systems has a beta of 0.722, which suggesting that the stock is 27.805% less volatile than S&P 500. In comparison Exact Sciences has a beta of 0.920, suggesting its less volatile than the S&P 500 by 7.968%.

  • Which is a Better Dividend Stock DCTH or EXAS?

    Delcath Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Exact Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Delcath Systems pays -- of its earnings as a dividend. Exact Sciences pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DCTH or EXAS?

    Delcath Systems quarterly revenues are $19.8M, which are smaller than Exact Sciences quarterly revenues of $706.8M. Delcath Systems's net income of $1.1M is higher than Exact Sciences's net income of -$101.2M. Notably, Delcath Systems's price-to-earnings ratio is -- while Exact Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Delcath Systems is 10.08x versus 3.71x for Exact Sciences. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DCTH
    Delcath Systems
    10.08x -- $19.8M $1.1M
    EXAS
    Exact Sciences
    3.71x -- $706.8M -$101.2M
  • Which has Higher Returns DCTH or ILMN?

    Illumina has a net margin of 5.4% compared to Delcath Systems's net margin of 12.58%. Delcath Systems's return on equity of -40.28% beat Illumina's return on equity of -34.38%.

    Company Gross Margin Earnings Per Share Invested Capital
    DCTH
    Delcath Systems
    85.62% $0.03 $80.2M
    ILMN
    Illumina
    65.61% $0.82 $4.4B
  • What do Analysts Say About DCTH or ILMN?

    Delcath Systems has a consensus price target of $24.08, signalling upside risk potential of 46.73%. On the other hand Illumina has an analysts' consensus of $106.53 which suggests that it could grow by 29.14%. Given that Delcath Systems has higher upside potential than Illumina, analysts believe Delcath Systems is more attractive than Illumina.

    Company Buy Ratings Hold Ratings Sell Ratings
    DCTH
    Delcath Systems
    4 0 0
    ILMN
    Illumina
    7 11 0
  • Is DCTH or ILMN More Risky?

    Delcath Systems has a beta of 0.722, which suggesting that the stock is 27.805% less volatile than S&P 500. In comparison Illumina has a beta of 1.349, suggesting its more volatile than the S&P 500 by 34.945%.

  • Which is a Better Dividend Stock DCTH or ILMN?

    Delcath Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Illumina offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Delcath Systems pays -- of its earnings as a dividend. Illumina pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DCTH or ILMN?

    Delcath Systems quarterly revenues are $19.8M, which are smaller than Illumina quarterly revenues of $1B. Delcath Systems's net income of $1.1M is lower than Illumina's net income of $131M. Notably, Delcath Systems's price-to-earnings ratio is -- while Illumina's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Delcath Systems is 10.08x versus 3.03x for Illumina. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DCTH
    Delcath Systems
    10.08x -- $19.8M $1.1M
    ILMN
    Illumina
    3.03x -- $1B $131M
  • Which has Higher Returns DCTH or NTRA?

    Natera has a net margin of 5.4% compared to Delcath Systems's net margin of -13.34%. Delcath Systems's return on equity of -40.28% beat Natera's return on equity of -19.19%.

    Company Gross Margin Earnings Per Share Invested Capital
    DCTH
    Delcath Systems
    85.62% $0.03 $80.2M
    NTRA
    Natera
    63.12% -$0.50 $1.3B
  • What do Analysts Say About DCTH or NTRA?

    Delcath Systems has a consensus price target of $24.08, signalling upside risk potential of 46.73%. On the other hand Natera has an analysts' consensus of $191.91 which suggests that it could grow by 22.11%. Given that Delcath Systems has higher upside potential than Natera, analysts believe Delcath Systems is more attractive than Natera.

    Company Buy Ratings Hold Ratings Sell Ratings
    DCTH
    Delcath Systems
    4 0 0
    NTRA
    Natera
    12 0 0
  • Is DCTH or NTRA More Risky?

    Delcath Systems has a beta of 0.722, which suggesting that the stock is 27.805% less volatile than S&P 500. In comparison Natera has a beta of 1.794, suggesting its more volatile than the S&P 500 by 79.445%.

  • Which is a Better Dividend Stock DCTH or NTRA?

    Delcath Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Natera offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Delcath Systems pays -- of its earnings as a dividend. Natera pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DCTH or NTRA?

    Delcath Systems quarterly revenues are $19.8M, which are smaller than Natera quarterly revenues of $501.8M. Delcath Systems's net income of $1.1M is higher than Natera's net income of -$66.9M. Notably, Delcath Systems's price-to-earnings ratio is -- while Natera's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Delcath Systems is 10.08x versus 11.00x for Natera. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DCTH
    Delcath Systems
    10.08x -- $19.8M $1.1M
    NTRA
    Natera
    11.00x -- $501.8M -$66.9M
  • Which has Higher Returns DCTH or STRR?

    Star Equity Holdings has a net margin of 5.4% compared to Delcath Systems's net margin of -9.1%. Delcath Systems's return on equity of -40.28% beat Star Equity Holdings's return on equity of -15.99%.

    Company Gross Margin Earnings Per Share Invested Capital
    DCTH
    Delcath Systems
    85.62% $0.03 $80.2M
    STRR
    Star Equity Holdings
    24.27% -$0.52 $73.2M
  • What do Analysts Say About DCTH or STRR?

    Delcath Systems has a consensus price target of $24.08, signalling upside risk potential of 46.73%. On the other hand Star Equity Holdings has an analysts' consensus of $8.50 which suggests that it could grow by 315.65%. Given that Star Equity Holdings has higher upside potential than Delcath Systems, analysts believe Star Equity Holdings is more attractive than Delcath Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    DCTH
    Delcath Systems
    4 0 0
    STRR
    Star Equity Holdings
    1 0 0
  • Is DCTH or STRR More Risky?

    Delcath Systems has a beta of 0.722, which suggesting that the stock is 27.805% less volatile than S&P 500. In comparison Star Equity Holdings has a beta of 0.871, suggesting its less volatile than the S&P 500 by 12.92%.

  • Which is a Better Dividend Stock DCTH or STRR?

    Delcath Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Star Equity Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Delcath Systems pays -- of its earnings as a dividend. Star Equity Holdings pays out -19.54% of its earnings as a dividend.

  • Which has Better Financial Ratios DCTH or STRR?

    Delcath Systems quarterly revenues are $19.8M, which are larger than Star Equity Holdings quarterly revenues of $12.9M. Delcath Systems's net income of $1.1M is higher than Star Equity Holdings's net income of -$1.2M. Notably, Delcath Systems's price-to-earnings ratio is -- while Star Equity Holdings's PE ratio is 0.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Delcath Systems is 10.08x versus 0.11x for Star Equity Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DCTH
    Delcath Systems
    10.08x -- $19.8M $1.1M
    STRR
    Star Equity Holdings
    0.11x 0.75x $12.9M -$1.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tesla Stock Overvalued or a Buy for the Next Decade?
Is Tesla Stock Overvalued or a Buy for the Next Decade?

Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…

Is Apple Stock Undervalued or Overvalued?
Is Apple Stock Undervalued or Overvalued?

For many years, Apple (NASDAQ:AAPL) was just about the perfect…

Where Will Palo Alto Networks Stock Be in 5 Years?
Where Will Palo Alto Networks Stock Be in 5 Years?

You know those companies that just refuse to slow down…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
68
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
58
TNXP alert for May 28

Tonix Pharmaceuticals Holding [TNXP] is up 1.57% over the past day.

Sell
37
ATS alert for May 28

ATS [ATS] is down 1.27% over the past day.

Buy
88
SMR alert for May 28

NuScale Power [SMR] is down 0.37% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock